Continuing Resolution Passage Means FDA Funds Stuck At 2019 Levels Through November
Executive Summary
The US Senate and House have both approved continuing resolution bills that President Trump is expected to sign shortly to keep the federal government running through 21 November – but that means that the FDA will be stuck at its 2019 funding level until then.
You may also be interested in...
Senate Wants To Keep FDA Device Center At Near-Current Levels In 2020 In 'Minibus' Funding Bill
The US Senate Appropriations Committee has drafted a “minibus” bill covering funding in fiscal year 2020 for five agencies – including the FDA – that would give the agency's device center only $387m. That would keep the center’s spending level approximately the same as it was in FY 2019. The Senate’s proposed spending level is in sharp contrast to what the US House wants for the device center, which is $420m.
US Senate Recommends Funding For FDA Device Shop In 2020 To Support Cybersecurity, Virtual Trials
The US Senate Appropriations Committee passed FDA funding levels for 2020 on 19 September that would support medical device cybersecurity and medtech manufacturing, but a continuing resolution measure is waiting in the wings to provide the full Senate more time to consider the measure before the new fiscal year starts on 1 October.
Lack Of Funding Stalls Major US FDA Cybersecurity Initiative
A public-private partnership board long touted by top US FDA officials to help address cybersecurity threats has hit a funding wall. The agency received less than half of what it asked for in the FY 2019 budget for its digital efforts, including its cybersecurity strategy, leading it to make some tough choices.